BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1630811)

  • 1. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
    Kwong YY; Husain Z; Biswas DK
    Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis.
    Husain Z; Fei YB; Roy S; Solt DB; Polverini PJ; Biswas DK
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1264-8. PubMed ID: 2493153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-erbB proto-oncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch.
    Wong DT; Biswas DK
    Oncogene; 1987; 2(1):67-72. PubMed ID: 3125508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
    Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C; Takayama H; Dickson RB; Merlino G
    Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary turmeric modulates DMBA-induced p21ras, MAP kinases and AP-1/NF-kappaB pathway to alter cellular responses during hamster buccal pouch carcinogenesis.
    Garg R; Ingle A; Maru G
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):428-39. PubMed ID: 18687351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MNU-induced point mutation and activation of c-Ha-ras oncogene in cell lines derived from human pancreas explants.
    Maheshwari KK; Parsa I; Marsh WH
    Biochem Int; 1990; 20(1):117-25. PubMed ID: 2183801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation.
    Nakazawa H; Aguelon AM; Yamasaki H
    Oncogene; 1992 Nov; 7(11):2295-301. PubMed ID: 1437151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
    Xu Y; Deng GR; Liang YY; Li C
    Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Point mutation of c-Ha-ras oncogene in oral cancers].
    Liu XF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Nov; 26(6):326-8, 388. PubMed ID: 1820236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between metastatic phenotype and steady expression of BGC-Ha-ras oncogene from metastasis cell lines in nude mice (abstract)].
    Li YJ
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):402-5. PubMed ID: 1349521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
    Richards CA; Short SA; Thorgeirsson SS; Huber BE
    Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of the Ha-ras oncogene in tumors induced in mice by transplacental exposure to 7,12-dimethylbenz(a)anthracene].
    Loktionov AS; Hollstein M; Martel N; Galendo D; Tomatis L; Yamasaki H
    Vopr Onkol; 1991; 37(3):297-303. PubMed ID: 1903226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.